(Q43803511)

27 November 2017

0 references

The subjective effects of MDMA and mCPP in moderate MDMA users (English)

1 reference

27 November 2017

Tancer ME

1

1 reference

PubMed ID

11714594

27 November 2017

Johanson CE

series ordinal

2

1 reference

27 November 2017

1 December 2001

1 reference

Drug and Alcohol Dependence

27 November 2017

1 reference

27 November 2017

65

1 reference

27 November 2017

97-101

1 reference

27 November 2017

1

1 reference

The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses.

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

The discriminative stimulus and subjective effects of d-amphetamine, phenmetrazine and fenfluramine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

m-Chlorophenylpiperazine as a probe of serotonin function

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

Serotonin-releasing effects of substituted piperazines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2801%2900146-6

7 January 2021

10.1016/S0376-8716(01)00146-6

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

11714594